Medication Development in Alcoholism: Apremilast Versus Placebo

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The primary hypotheses under test are that alcohol dependent subjects treated with apremilast will report decreased craving for alcohol following alcohol exposure in the laboratory and report significantly less drinking under naturalistic conditions, than those treated with placebo.
Epistemonikos ID: 135c0a7db182982f97ea13fba00110dee54c3cdf
First added on: May 20, 2024